Bukwang Pharm Co Ltd (003000)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Bukwang Pharm Co Ltd (003000) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014380
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bukwang PharmCo Ltd (BUKWANG) is a pharmaceutical company which develops pharmaceutical products and new drugs. The company’s product portfolio includes levovir, legalon, dexid, thioctacid, lonasen, ixel, Orfil, azeptin, asima among others. Its pipeline products comprise MLR-1023, JM-010, JM-012 and SOL-804. BUKWANG offers its products in the therapeutic areas of Liver disease, Diabetes, Central Nervous System (CNS) disorders, Respiratory diseases, Prostate cancer, Parkinson’s disease and others. The company also offers services such as clinical development, regulatory development, and product development. Its products are used for treating hepatitis B-virus, diabetic neuropathy, liver damage, seasonal allergies and bronchial asthma. It operates through a research and development center located in Korea. BUKWANG is headquartered in Seoul, South Korea.

Bukwang Pharm Co Ltd (003000) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bukwang Pharma Enters into Partnership with TVM Capital Life Science 10
Bukwang Pharma Enters Into Co-Development Agreement With LSK BioPartner And West Coast Clinical 11
Licensing Agreements 13
Sumitomo Dainippon Pharma Enters into Licensing Agreement with Bukwang Pharm 13
Melior Pharma Enters Into Licensing Agreement With Bukwang Pharma 14
Acquisition 15
Bukwang Pharma Acquires Contera Pharma 15
Bukwang Pharm Co Ltd – Key Competitors 16
Bukwang Pharm Co Ltd – Key Employees 17
Bukwang Pharm Co Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bukwang Pharm Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Bukwang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bukwang Pharma Enters into Partnership with TVM Capital Life Science 10
Bukwang Pharma Enters Into Co-Development Agreement With LSK BioPartner And West Coast Clinical 11
Sumitomo Dainippon Pharma Enters into Licensing Agreement with Bukwang Pharm 13
Melior Pharma Enters Into Licensing Agreement With Bukwang Pharma 14
Bukwang Pharma Acquires Contera Pharma 15
Bukwang Pharm Co Ltd, Key Competitors 16
Bukwang Pharm Co Ltd, Key Employees 17
Bukwang Pharm Co Ltd, Other Locations 18
Bukwang Pharm Co Ltd, Subsidiaries 18

★海外企業調査レポート[Bukwang Pharm Co Ltd (003000)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Future Fund:企業の戦略的SWOT分析
    Future Fund - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Exelon Generation Company LLC-エネルギー分野:企業M&A・提携分析
    Summary Exelon Generation Company, LLC (Exelon Generation), a subsidiary of Exelon Corporation, generates, transmits and markets electricity. It sells renewable energy and other energy-related products and services. Geographically, it has operations in the Mid-Atlantic, Midwest, New England, New Yor …
  • Healthcare Services Group Inc (HCSG):企業の財務・戦略的SWOT分析
    Healthcare Services Group Inc (HCSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Nohla Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nohla Therapeutics Inc (Nohla Therapeutics) focuses on the development of universal, off-the-shelf cell therapies for the treatment of hematologic malignancies and other critical diseases. The company develops clinical, preclinical and discovery programs based on its proprietary notch ligand …
  • Novotech (Australia) Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Novotech (Australia) Pty Ltd (Novotech) is a contract research organization that offers clinical development services. The organization’s services include clinical trials, data management, biostatistics analysis, audits, regulatory affairs, medical writing, site management and commercializat …
  • Catalyst Paper Corporation:企業の戦略的SWOT分析
    Catalyst Paper Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Nutritional Resources Inc:企業の戦略・SWOT・財務分析
    Nutritional Resources Inc - Strategy, SWOT and Corporate Finance Report Summary Nutritional Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Smith & Nephew Plc (SN.):企業の財務・戦略的SWOT分析
    Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • South Jersey Industries Inc (SJI):石油・ガス:M&Aディール及び事業提携情報
    Summary South Jersey Industries Inc (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also offer …
  • Boryung Medience Corporation:企業の戦略・SWOT・財務情報
    Boryung Medience Corporation - Strategy, SWOT and Corporate Finance Report Summary Boryung Medience Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PetVivo Holdings Inc (PETV):企業の製品パイプライン分析2018
    Summary PetVivo Holdings Inc (PetVivo Holdings), formerly Technologies Scan Corp, is a biomedical device company. The company offers licensing and commercialization of medical devices and therapeutics to treat pets and animals suffering from arthritis and other afflictions. Its products include Kush …
  • Indian Oil Corporation Limited:企業の戦略・SWOT・財務分析
    Indian Oil Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Indian Oil Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Singapore Technologies Electronics Ltd:企業の戦略・SWOT・財務情報
    Singapore Technologies Electronics Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Technologies Electronics Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Exonate Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Exonate Ltd (Exonate) is a biopharmaceutical company that discovers and develops small molecule drugs which modulates the alternative mRNA splicing for the treatment of unmet medical needs. The comany's alternative mRNA splicing is modulated in disease states that results in the pathological …
  • Sequa Petroleum NV (MLSEQ):企業の財務・戦略的SWOT分析
    Summary Sequa Petroleum NV (Sequa Petroleum) is an oil and gas company. It develops, acquires, monetises, produces and finances oil and natural gas assets. The company holds assets in Europe, Central and West Africa and the Middle East. Sequa Petroleum has a large development and producing area in N …
  • PowerFilm, Inc.:企業の戦略的SWOT分析
    PowerFilm, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • EuroSibEnergo Plc:企業の戦略的SWOT分析
    EuroSibEnergo Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Covestro AG (1COV):企業の財務・戦略的SWOT分析
    Covestro AG (1COV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Ahli Bank Qsc
    Ahli Bank Qsc - Strategy, SWOT and Corporate Finance Report Summary Ahli Bank Qsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Invetech Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Invetech Pty Ltd (Invetech), a subsidiary of Danaher Corp is a manufacturer of custom automation systems. The company offers services which include product development, instrument development, custom automation and contract manufacturing. It specializes in applied sciences, automated measure …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆